Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
SX-PCK9
print preview
bookmark
share with colleague
General Information
Company
Serometrix LLC
Description
Proprotein convertase subtilisin/kexin type 9 (PCSK9) antagonist
Molecular Target
Proprotein convertase subtilisin/kexin type 9 (PCSK9)
Mechanism of Action
Latest Stage of Development
Preclinical
Indication
Hypercholesterolemia
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy